Roche is moving its novel antibiotic zosurabalpin into phase 3 testing for carbapenem-resistant Acinetobacter baumannii (CRAB), a 'superbug' that is considered an 'urgent threat' by the CDC, in ...

AbbVie has claimed FDA approval for Emblaveo, a new antibiotic product to treat complicated intra-abdominal infections (cIAI), including those caused by Gram-negative bacteria that represent a ...

Antibiotics are substances that inhibit the growth of bacteria. They work by killing bacteria or preventing their reproduction, and may be synthesized chemically or by naturally-occurring or ...

Markets move not on headlines but on signal. Despite escalating noise out of the Middle East and some ugly economic data, ...

Today, antibiotics are the third largest-selling class of drugs, with a worldwide annual market estimated between $7 and $22 billion. More than 150 antibacterial drugs have now been approved in ...

Chronic or recurring yeast infections can affect your daily life. Learn what causes them and what you can do to treat and prevent them.